Literature DB >> 6193973

Bradykinin contracts the pupillary sphincter and evokes ocular inflammation through release of neuronal substance P.

G Bynke, R Håkanson, J Hörig, S Leander.   

Abstract

Bradykinin contracts the isolated rabbit sphincter pupillae muscle. The contraction produced by 10(-8) M bradykinin was resistant to atropine but not to tetrodotoxin, suggesting a non-cholinergic nervous mechanism. The contraction was blocked by specific substance P (SP) antagonists, suggesting the involvement of SP. The SP antagonists tested were [D-Pro2,D-Trp7,9]SP-(1-11) and [Arg5,D-Trp7,9]SP-(5-11). The bradykinin-induced contraction exhibited marked tachyphylaxis in contrast to that induced by SP. It appears that the tachyphylaxis reflects the depletion of a bradykinin-sensitive neuronal pool of SP. Injection of bradykinin into the vitreous chamber of the rabbit eye caused miosis and disruption of the blood-aqueous barrier (manifested as aqueous flare). A second administration of bradykinin a few hours after the first injection evoked a reduced response; the response to SP upon repeated administration was unchanged. Atropine was without effect on the response to bradykinin whereas tetrodotoxin and the SP antagonists reduced the response. The results suggest that bradykinin causes miosis and aqueous flare at least partly through local release of neuronal SP.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6193973     DOI: 10.1016/0014-2999(83)90172-3

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  8 in total

1.  Effects of ruthenium red and capsazepine on C-fibres in the rabbit iris.

Authors:  Z Y Wang; R Håkanson
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

2.  A comparison of bradykinin- and capsaicin-induced myocardial and coronary effects in isolated perfused heart of guinea-pig: involvement of substance P and calcitonin gene-related peptide release.

Authors:  S Manzini; F Perretti; L De Benedetti; P Pradelles; C A Maggi; P Geppetti
Journal:  Br J Pharmacol       Date:  1989-06       Impact factor: 8.739

3.  New, long-acting, potent bradykinin antagonists.

Authors:  F Lembeck; T Griesbacher; M Eckhardt; S Henke; G Breipohl; J Knolle
Journal:  Br J Pharmacol       Date:  1991-02       Impact factor: 8.739

4.  Substance P antagonists and mucociliary activity in rabbit.

Authors:  S Lindberg; U Mercke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-06       Impact factor: 3.000

5.  Neurogenic inflammation in skin blisters.

Authors:  R D Helme; D M White; P V Andrews
Journal:  Exp Brain Res       Date:  1985       Impact factor: 1.972

6.  Long-term administration of a substance P antagonist, (D-Pro2, D-Trp7,9)-SP, abolishes the response to ocular trauma.

Authors:  G Bynke; R Håkanson; J Hörig; K Folkers
Journal:  Experientia       Date:  1984-04-15

7.  Protein expression, biochemical pharmacology of signal transduction, and relation to intraocular pressure modulation by bradykinin B₂ receptors in ciliary muscle.

Authors:  Najam A Sharif; Shouxi Xu; Linya Li; Parvaneh Katoli; Curtis R Kelly; Yu Wang; Shutong Cao; Rajkumar Patil; Shahid Husain; Laura Klekar; Daniel Scott
Journal:  Mol Vis       Date:  2013-06-15       Impact factor: 2.367

8.  Sensitization of neonatal rat lumbar motoneuron by the inflammatory pain mediator bradykinin.

Authors:  Mouloud Bouhadfane; Attila Kaszás; Balázs Rózsa; Ronald M Harris-Warrick; Laurent Vinay; Frédéric Brocard
Journal:  Elife       Date:  2015-03-17       Impact factor: 8.140

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.